About Splendid Lab
Splendid Lab is a Healthcare company based in Pune (India) founded in 2013 by Abhay Gandhi. It operates as a reference standards, research chemicals, and custom synthesis are supplied. Splendid Lab has raised $172.5 thousand across 2 funding rounds. Its Indian entity Cro Splendid Lab Private Limited reported revenue of ₹1.83 Cr. Splendid Lab offers products and services including Pharmaceutical Impurities, Custom Synthesis, and Drug Intermediates. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Analytical Testing. Its competitors include AFYREN, Clearbridge Health, Phylos Bioscience, Omass and Spore Biotechnologies and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
Splendid Lab was established in 2013 in Pune, India, as a provider of integrated services within the pharmaceutical and biotechnology sectors. Custom synthesis on a small scale, analytical services, and outsourcing are offered, including labeled APIs and metabolites. Customized and specialty packaging services are also provided. Clients encompass global pharmaceutical firms, biotechnology companies, specialty fine chemicals producers, clinical and bio-analytical CROs, universities, and research institutions.
- Headquarters Pune, India
- Founders Abhay Gandhi
- SectorsHealthcare
- Website splendidlab.com
- Social LinkedIn X Facebook
- Legal Name Cro Splendid Lab Private Limited
- Date of Incorporation 22 Mar, 2016
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹1.83 Cr
FY 2025 · -10% YoY
- Net Profit₹6 Lakh
FY 2025 · 3% margin
- EBITDA₹14.6 Lakh
FY 2025 · 8% margin
- Total Equity Funding$172.5K (USD)
in 2 rounds
- Latest Funding Round$70K (USD), Seed
Aug 2014
Associated legal entities of Splendid Lab
Splendid Lab operates through Cro Splendid Lab Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cro Splendid Lab Private Limited CIN U74999PN2016PTC158959 | Active | 22 Mar 2016 | Pune, Maharashtra | ₹1.8 Cr | – | 2 | View details |
Products & Services of Splendid Lab
Splendid Lab offers a comprehensive portfolio of products and services, including Pharmaceutical Impurities, Custom Synthesis, and Drug Intermediates.
Supplies working references and standards for pharmaceutical research.
Provides tailored organic synthesis for drug development needs.
Offers intermediates for pharmaceutical and biotech applications.
Funding Insights of Splendid Lab
Splendid Lab has successfully raised a total of $172.5K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $70 thousand completed in August 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $172,500
- Total Rounds 2
- Last Round Seed — $70,000
- First Round $102,500
(Aug 2013)
All 2 funding rounds of Splendid Lab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2014 | $70,000 | Seed | – | – | – |
| Aug 2013 | $102,500 | Seed | – | – | – |
Board of directors of Cro Splendid Lab Private Limited (Splendid Lab)
Cro Splendid Lab Private Limited is the primary company behind Splendid Lab. The board of Cro Splendid Lab Private Limited currently have 2 directors; the longest-serving is Pritam Abhay Gandhi, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pritam Abhay Gandhi DIN 07456990 | Director | 22 Mar 2016 | 10 yrs 6 mo | Cro Splendid Lab Private Limited |
| Abhay Arvind Gandhi DIN 07456988 | Director | 22 Mar 2016 | 10 yrs 6 mo | Cro Splendid Lab Private Limited |
People of Splendid Lab
1 people are tracked at Splendid Lab (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for Splendid Lab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Splendid Lab
Figures of Cro Splendid Lab Private Limited, the primary company behind Splendid Lab, for FY 2025. Revenue was ₹1.83 Cr (-10% year on year). Net profit was ₹6 Lakh (3% margin). EBITDA was ₹14.6 Lakh (8% margin). Revenue has grown at a compounded annual rate of +5% over three years and -3% over five years.
- ₹1.83 CrRevenue · FY 2025 · -10% YoY
- ₹6 LakhNet profit · 3% margin
- ₹14.6 LakhEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- +5%Revenue CAGR, 3 years
- -3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cro Splendid Lab Private Limited are on its company page.
Detailed financial statements for Splendid Lab
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Splendid Lab
3 dated milestones of Splendid Lab across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Splendid Lab is founded.
- Funding First funding round of $102K.
- Funding Latest funding round, Seed, of $70K.
Competitors of Splendid Lab
Splendid Lab has 10 listed competitors in our database, 7 of them funded. They include AFYREN, Clearbridge Health, Phylos Bioscience, Omass and Spore Biotechnologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| afyren.com | 2012 | Paris, France | $25.59M | – | Analytical services are provided for microbiology, chemistry, and bioprocesses sectors. | |
| clearbridgehealth.com | 2010 | Singapore | – | – | Precision medicine services including urine and tissue testing are provided. | |
| phylos.bio | 2014 | Portland, United States | $28.41M | 61 | Developer of cannabis breeding tools for agriculture & other health purposes | |
| omasstech.com | 2016 | Oxford, United Kingdom | $19.32M | 39 | Native mass spectrometry services for protein characterization are provided. | |
| spore.bio | 2022 | Paris, France | $31.61M | – | Microbial detection technology is developed for life science industries. | |
| crawfordscientific.com | 1985 | Strathaven, United Kingdom | $9.78M | 50 | Service provider in analytical testing | |
| perfectusbiomed.com | 2012 | Daresbury, United Kingdom | $396,023 | 57 | Provides services for research-based approach for microbiological testing | |
| groupecarso.com | 1992 | Venissieux, France | – | – | Analytical services for environmental and health testing are offered. | |
| ibet.pt | 1989 | Oeiras, Portugal | – | – | Genomics and analytical services are provided by iBET in Portugal. | |
| biopsin.com | 2018 | Singapore | $175,000 | – | Real-time microbial detection system is developed for product testing. |
Detailed competitors of Splendid Lab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Splendid Lab
The website of Splendid Lab (splendidlab.com) receives about 1.2K visits a month.
- Monthly visits1.2K
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Splendid Lab (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Splendid Lab
Splendid Lab was founded in 2013.
Splendid Lab is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Splendid Lab is a funded company, having raised a total of $172.5K across 2 funding rounds to date. The company's 1st funding round was a Seed of $102.5K, raised on Aug 2013.
The primary company behind Splendid Lab, Cro Splendid Lab Private Limited, reported revenue of ₹1.83 Cr for FY 2025, down 10% year on year.
Splendid Lab was established in 2013 in Pune, India, as a provider of integrated services within the pharmaceutical and biotechnology sectors. Custom synthesis on a small scale, analytical services, and outsourcing are offered, including labeled APIs and metabolites. Customized and specialty packaging services are also provided. Clients encompass global pharmaceutical firms, biotechnology companies, specialty fine chemicals producers, clinical and bio-analytical CROs, universities, and research institutions.
Splendid Lab's top competitors include AFYREN, Perfectus Biomed and Spore Biotechnologies.
Splendid Lab offers Pharmaceutical Impurities, Custom Synthesis, and Drug Intermediates.
Splendid Lab operates through Cro Splendid Lab Private Limited.
The legal entities of Splendid Lab currently have 2 directors, including Pritam Abhay Gandhi, Abhay Arvind Gandhi.